These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2868656)

  • 1. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
    Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
    Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
    Goto Y
    Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic blocking agents and lipoprotein lipase activity.
    Rubba P; De Simone B; Marotta T; Leccia G; Soro S; Ferrara LA
    J Endocrinol Invest; 1989 Feb; 12(2):119-22. PubMed ID: 2754182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
    Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B. Comparison of prazosin and atenolol.
    Rouffy J; Jaillard J
    Am J Med; 1986 Feb; 80(2A):100-3. PubMed ID: 3511689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of prazosin versus propranolol on plasma lipoprotein lipids in patients receiving hemodialysis.
    Harter HR; Meltzer VN; Tindira CA; Naumovich AD; Goldberg AP
    Am J Med; 1986 Feb; 80(2A):82-9. PubMed ID: 3511693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M; Hurt E; Silva H; Urbina-Quintana A; Hernández-Pieretti O; Feldstein E; Camejo G
    Am J Med; 1986 Feb; 80(2A):109-13. PubMed ID: 3080882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
    Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
    Dimmitt SB; Williams PD; Croft KD; Beilin LJ
    Clin Sci (Lond); 1998 Jun; 94(6):573-8. PubMed ID: 9854453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive therapy and lipid metabolism].
    Krone W; Müller-Wieland D; Greten H
    Klin Wochenschr; 1984 Mar; 62(5):193-202. PubMed ID: 6143851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
    Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
    Schoonderwoerd K; Hülsmann WC; Jansen H
    Biochim Biophys Acta; 1984 Oct; 795(3):481-6. PubMed ID: 6148107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic alpha 1-adrenergic blockade, serum triacylglycerols, and tissue lipoprotein lipase activity in rats fed diets high in starch or sucrose.
    Deshaies Y; Martineau MJ; LaLonde J
    Nutrition; 1991; 7(2):109-15; discussion 115-6. PubMed ID: 1686980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.
    Rouffy J; Jaillard J
    Am J Med; 1984 Feb; 76(2A):105-8. PubMed ID: 6702861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha- and beta-blocker therapy on blood lipids: European experience.
    Leren P
    Am J Med; 1984 Feb; 76(2A):67-71. PubMed ID: 6142644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prazosin and beta-blocker monotherapy on serum lipids: a cross-over, placebo-controlled study.
    Magarian EO; Dietz AJ; Freeman DS; Carlson JD
    J Clin Pharmacol; 1987 Oct; 27(10):756-61. PubMed ID: 2892862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension.
    Schobel HP; Langenfeld M; Gatzka C; Schmieder RE
    Am Heart J; 1996 Nov; 132(5):1004-9. PubMed ID: 8892775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic control of lipid metabolism.
    Smith U
    Acta Med Scand Suppl; 1983; 672():41-4. PubMed ID: 6138932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial antihypertensive drug therapy. Final report of a randomized, controlled trial comparing alpha-blocker and diuretic.
    Stamler R; Stamler J; Gosch FC; Berkson DM; Dyer AR; Hershinow P
    Hypertension; 1988 Dec; 12(6):574-81. PubMed ID: 3060429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.